Within this consortium we are now successfully performing minimally-invasive ultrasound-guided joint biopsies on American patients who have active RA, and the samples from these patients are being studied with some of the newest and most advanced testing in existence with the goal to identify markers within the joint lining that can be used to predict medication outcomes and bring the era of trial-and-error medication switching to an end.
|Effective start/end date
|9/1/20 → 8/31/22
- University of California, San Diego (704132 // W81XWH2010733)
- U.S. Army Medical Research and Materiel Command (704132 // W81XWH2010733)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.